COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
PET/MRI in the Diagnosis of Chronic Pain
Trial ID or NCT#
Status
RECRUITING
Purpose
Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using [18F]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of [18F]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.
Official Title
Use of [18F]FTC-146 PET/MRI in the Diagnosis of Chronic Pain
Eligibility Criteria
- Healthy Volunteers: 1. At least 18 years old. Pain Patients: 1. At least 18 years old. 2. Chronic pain (nociceptive, neuropathic or mixed pain) lasting greater than 2 months. 3. Pain level of at least 4/10 on a 0-10 Comparative Pain Scale.
- Healthy Volunteers: 1. Pain 2. Pain Medication 3. MRI incompatible 4. Pregnant or nursing 5. Non-English speaker Pain Patients: 1. MRI incompatible 2. Pregnant or nursing 3. Non-English speaker
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Peter W Cipriano, BA
(650) 380-3782
View on ClinicalTrials.gov
About this Clinical Trial
PET/MRI in the Diagnosis of Chronic Pain
Your Message Will Go To
Peter W Cipriano, BA650-380-3782